Comparative Label-Free Proteomics of a High-Glucose Syncytialised Trophoblast Model Identifies Mitochondrial Fission Factor (MFF) as a Candidate Serum Biomarker Associated with Hyperglycaemic Pregnancy
- 1Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India
- 2TestGo, The Colony, TX 75056, USA
- 3Yoda Diagnostics Pvt Ltd., Greenlands, Ameerpet, Hyderabad 500016, Telangana, India
Abstract
Placental protein markers of maternal hyperglycaemia in gestational diabetes mellitus (GDM) remain scarce. We aimed to find trophoblast proteins that change under high glucose and to test whether a lead candidate is also raised in maternal serum. In our established insulin-resistant model, we used label-free liquid chromatography–tandem mass spectrometry (LC-MS/MS) to compare BeWo cells syncytialised with forskolin/8-Br-cAMP in high-glucose (25 mM) medium, with or without vascular endothelial growth factor (VEGF), with undifferentiated control cells in normoglycaemic (5 mM) medium (n = 3 per group); glucose and differentiation therefore varied together. Of 3528 protein groups, 388 were differentially abundant (24 at Benjamini–Hochberg q < 0.05). Mitochondrial fission factor (MFF), the outer-membrane receptor for dynamin-related protein 1 (DRP1), increased 4.5-fold (q = 0.040), whereas DRP1 was unchanged; mitochondrial calcium-uniporter components, pyruvate dehydrogenase kinase 3 and glycogen synthase 1 also increased. VEGF did not alter this signature (MFF: 0.91-fold, p = 0.71). Enzyme-linked immunosorbent assay (ELISA) confirmed higher MFF in high-glucose cell lysates (+48%) and, independently of in vitro differentiation, in gestational-day-7 serum of streptozotocin-treated hyperglycaemic pregnant rats (+41%; both p < 0.001; n = 3 per group), consistent with reported increases of MFF in GDM placentae. As serum was sampled after hyperglycaemia developed, these data show association, not prediction. MFF is a candidate serum biomarker of hyperglycaemic pregnancy; studies separating glucose from differentiation and validation in women are needed.
Related
- PARP1/2-linked ADP-ribosylation impairs trophoblast mitochondrial respiration in a TNF-α model of inflammation-mediated preeclampsia.
- Comparative proteomics and immunoreactivity of Lonomia venomous caterpillars identify hemolins as predominant toxins
- Comparative Proteomics Reveals Cell-Type-Specific Heterogeneity of Human Neural Cell-Derived Extracellular Vesicles
- First complete mitochondrial genome of star fruit (Averrhoa carambola L.): assembly, comparative analysis, and phylogenetic placement
- Comparative S-acyl-proteomics reveals post-translational modulation of fungal purine metabolism for Verticillium wilt
BibTeX
@article{sharma2026comparative,
title = {{Comparative Label-Free Proteomics of a High-Glucose Syncytialised Trophoblast Model Identifies Mitochondrial Fission Factor (MFF) as a Candidate Serum Biomarker Associated with Hyperglycaemic Pregnancy}},
author = {Amarish Kumar Sharma and Chaitanya Yalavarthi and Pooja Savithri and Gaddipati Giridhar Rahul and Manoj Kumar Jena},
journal = {Cells},
year = {2026},
month = nov,
doi = {10.3390/cells15212037},
url = {https://www.mdpi.com/2073-4409/15/21/2037},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparative Label-Free Proteomics of a High-Glucose Syncytialised Trophoblast Model Identifies Mitochondrial Fission Factor (MFF) as a Candidate Serum Biomarker Associated with Hyperglycaemic Pregnancy
AU - Amarish Kumar Sharma
AU - Chaitanya Yalavarthi
AU - Pooja Savithri
AU - Gaddipati Giridhar Rahul
AU - Manoj Kumar Jena
PY - 2026
DA - 2026/11/09
JO - Cells
DO - 10.3390/cells15212037
UR - https://www.mdpi.com/2073-4409/15/21/2037
AB - Placental protein markers of maternal hyperglycaemia in gestational diabetes mellitus (GDM) remain scarce. We aimed to find trophoblast proteins that change under high glucose and to test whether a lead candidate is also raised in maternal serum. In our established insulin-resistant model, we used label-free liquid chromatography–tandem mass spectrometry (LC-MS/MS) to compare BeWo cells syncytialised with forskolin/8-Br-cAMP in high-glucose (25 mM) medium, with or without vascular endothelial growth factor (VEGF), with undifferentiated control cells in normoglycaemic (5 mM) medium (n = 3 per group); glucose and differentiation therefore varied together. Of 3528 protein groups, 388 were differentially abundant (24 at Benjamini–Hochberg q < 0.05). Mitochondrial fission factor (MFF), the outer-membrane receptor for dynamin-related protein 1 (DRP1), increased 4.5-fold (q = 0.040), whereas DRP1 was unchanged; mitochondrial calcium-uniporter components, pyruvate dehydrogenase kinase 3 and glycogen synthase 1 also increased. VEGF did not alter this signature (MFF: 0.91-fold, p = 0.71). Enzyme-linked immunosorbent assay (ELISA) confirmed higher MFF in high-glucose cell lysates (+48%) and, independently of in vitro differentiation, in gestational-day-7 serum of streptozotocin-treated hyperglycaemic pregnant rats (+41%; both p < 0.001; n = 3 per group), consistent with reported increases of MFF in GDM placentae. As serum was sampled after hyperglycaemia developed, these data show association, not prediction. MFF is a candidate serum biomarker of hyperglycaemic pregnancy; studies separating glucose from differentiation and validation in women are needed.
SN - 2073-4409
ER -